Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

Item
http://www.wikidata.org/entity/Q40207428
Mast cell homeostasis and the JAK-STAT pathwayRIN3 is a negative regulator of mast cell responses to SCF.Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistagesEnhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosisPQJS380: a novel lead compound to induce apoptosis in acute lymphoblastic leukemia cellsSilencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition.CADM1 isoforms differentially regulate human mast cell survival and homotypic adhesion.Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells.Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin.Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic LeukemiasMastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.Targeted Treatment Options in Mastocytosis.
P2860

Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

Item
http://www.wikidata.org/entity/Q40207428
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of MCL1 as a no ...... des and synergism with PKC412.
@en
type
label
Identification of MCL1 as a no ...... des and synergism with PKC412.
@en
prefLabel
Identification of MCL1 as a no ...... des and synergism with PKC412.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Identification of MCL1 as a no ...... ides and synergism with PKC412
@en
P2093
P304
P31
P356
10.1182/BLOOD-2006-07-032714
P407
P433
P478
P50
P577
P5875
P698
P921